Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hausch

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Pain|March 17, 2022
Duration of Reduction in Enduring Stress-Induced Hyperalgesia Via FKBP51 Inhibition Depends on Timing of Administration Relative to Traumatic Stress ExposureBritannia J Wanstrath, Samuel A McLean, Ying Zhao, et al.
Chembiochem : a European Journal of Chemical Biology|April 22, 2021
Development of NanoBRET-Binding Assays for FKBP-Ligand Profiling in Living CellsMonika T Gnatzy, Thomas M Geiger, Angela Kuehn, et al.
Nature Medicine|February 10, 2015
A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing diseaseMathias Riebold, Christian Kozany, Lee Freiburger, et al.
Science (New York, N.Y.)|September 28, 2002
Structural basis for gluten intolerance in celiac sprueLu Shan, Øyvind Molberg, Isabelle Parrot, et al.
Journal of Medicinal Chemistry|January 22, 2025
Macrocyclization as a Strategy for Kinetic Solubility Improvement: A Comparative Analysis of Matched Molecular PairsCarlo Walz, Moritz Spiske, Magnus Walter, et al.
FEBS Letters|April 21, 2009
XAP2 inhibits glucocorticoid receptor activity in mammalian cellsAnna Laenger, Isabelle Lang-Rollin, Christian Kozany, et al.
Journal of Medicinal Chemistry|March 5, 2021
Structure-Based Design of High-Affinity Macrocyclic FKBP51 InhibitorsMichael Bauder, Christian Meyners, Patrick L Purder, et al.
Addiction Biology|June 8, 2019
The selective FKBP51 inhibitor SAFit2 reduces alcohol consumption and reinstatement of conditioned alcohol effects in miceLoretta König, Liubov S Kalinichenko, Sabine E Huber, et al.
Angewandte Chemie (International Ed. in English)|January 3, 2025
Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker DerivatizationMoritz Spiske, Christian Meyners, Michael Bauder, et al.
Science Translational Medicine|February 12, 2016
The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signalingMaria Maiarù, Keri K Tochiki, Marc B Cox, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Pain|March 17, 2022
Duration of Reduction in Enduring Stress-Induced Hyperalgesia Via FKBP51 Inhibition Depends on Timing of Administration Relative to Traumatic Stress ExposureBritannia J Wanstrath, Samuel A McLean, Ying Zhao, et al.
Chembiochem : a European Journal of Chemical Biology|April 22, 2021
Development of NanoBRET-Binding Assays for FKBP-Ligand Profiling in Living CellsMonika T Gnatzy, Thomas M Geiger, Angela Kuehn, et al.
Nature Medicine|February 10, 2015
A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing diseaseMathias Riebold, Christian Kozany, Lee Freiburger, et al.
Science (New York, N.Y.)|September 28, 2002
Structural basis for gluten intolerance in celiac sprueLu Shan, Øyvind Molberg, Isabelle Parrot, et al.
Journal of Medicinal Chemistry|January 22, 2025
Macrocyclization as a Strategy for Kinetic Solubility Improvement: A Comparative Analysis of Matched Molecular PairsCarlo Walz, Moritz Spiske, Magnus Walter, et al.
FEBS Letters|April 21, 2009
XAP2 inhibits glucocorticoid receptor activity in mammalian cellsAnna Laenger, Isabelle Lang-Rollin, Christian Kozany, et al.
Journal of Medicinal Chemistry|March 5, 2021
Structure-Based Design of High-Affinity Macrocyclic FKBP51 InhibitorsMichael Bauder, Christian Meyners, Patrick L Purder, et al.
Addiction Biology|June 8, 2019
The selective FKBP51 inhibitor SAFit2 reduces alcohol consumption and reinstatement of conditioned alcohol effects in miceLoretta König, Liubov S Kalinichenko, Sabine E Huber, et al.
Angewandte Chemie (International Ed. in English)|January 3, 2025
Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker DerivatizationMoritz Spiske, Christian Meyners, Michael Bauder, et al.
Science Translational Medicine|February 12, 2016
The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signalingMaria Maiarù, Keri K Tochiki, Marc B Cox, et al.
Pageof 13